India to Algeria: Serum Export Trade Route

The India to Algeria Serum corridor is one of India's established pharmaceutical export routes, with 37 shipments documented worth a combined $5.5M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's serum manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $147.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with serum's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 25.5%, placing it at rank #2 among India's top serum export destinations globally.

On the import side, key buyers of Indian serum in Algeria include INSTITUT PASTEUR D?ALGERIE, INSTITUT PASTEUR D ALGERIE, INSTITUT PASTEUR DALGERIE and 6 others. INSTITUT PASTEUR D?ALGERIE is the single largest importer with 8 shipments valued at $2.9M USD.

India's serum exports to Algeria are driven primarily by a handful of large-scale manufacturers. BHARAT SERUMS AND VACCINES LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Algeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, BHARAT SERUMS AND VACCINES LIMITED , SERUM INSTITUTE OF INDIA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $147.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as equirab 1000iu/5ml [rabies antiserum - e and equirab 1000iu/5ml [rabies antiserum -equine], suggesting that buyers in Algeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, INSTITUT PASTEUR D?ALGERIE is the largest importer with 8 shipments worth $2.9M USD — representing 52% of all serum imports from India on this route. A total of 9 buyers are active on this corridor.